查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
蛋白質晶片的全球市場 - 產業分析，規模，佔有率，成長，趨勢，預測(2023年～2030年):各產品，各技術，各等級，各用途，各終端用戶，各地區
市場調查報告書
商品編碼
1318090

蛋白質晶片的全球市場 - 產業分析，規模，佔有率，成長，趨勢，預測(2023年～2030年):各產品，各技術，各等級，各用途，各終端用戶，各地區

Protein Chip Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
出版日期: | 出版商: Fairfield Market Research | 英文 220 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

由於慢性病的流行和對先進治療方案的需求不斷增加，全球蛋白質芯片市場呈現快速增長。醫療行業的發展以及對改進疾病監測和臨床診斷的需求不斷增長，對市場增長產生了重大影響。蛋白質微陣列方法可以在一次實驗中進行廣泛的分析，已成為一個獨特的賣點，並有助於市場擴張。根據費爾菲爾德市場研究公司的初步研究，全球癌症的高患病率預計將支持市場增長。

蛋白質芯片市場受益於 COVID-19 爆發和癌症流行

COVID-19 的爆發凸顯了診斷在控制疫情方面的重要性，導致對功能分析方法的需求激增。因此，研究人員專注於通過各種檢測來識別蛋白質-病毒相互作用，使功能分析成為一個利潤豐厚的增長領域。

另一方面，癌症仍然是全世界預期壽命縮短的主要原因。據世界衛生組織(WHO)稱，到2020年，將有超過1900萬新發癌症病例和約1000萬癌症相關死亡。蛋白質芯片在高效癌症診斷中的關鍵作用是通過並行跟?各種蛋白質相互作用、靶標、小分子、蛋白激?底物和蛋白質-磷脂相互作用，實現快速、輕鬆的診斷，並推動市場需求。蛋白質芯片在分子生物學和生物化學領域的廣泛應用，以及個性化醫療領域的不斷增長，進一步增強了其在醫療行業的重要性。

蛋白質組學成為蛋白質芯片的主要應用

蛋白質組學是 2019 年蛋白質芯片的領先應用領域，預計未來幾年將保持這一地位。其在生物醫學研究和藥物發現中的廣泛應用預計將成為市場的主要收入來源。蛋白質組學應用於多種技術，包括表面流體色譜、層析、X射線晶體學、蛋白質分級分離、光譜學、表面等離子體共振和電泳。準確分析體內結果的能力使其成為研究腫瘤耐藥機制、疾病病因和治療開發的重要工具。

北美和歐洲引領全球蛋白質芯片市場

預計2021-2026年北美將保持其在全球蛋白質芯片市場的主導地位。該地區領先的生物技術公司預計將大力投資於創新技術的研發。隨著癌症和 COVID-19 患病率上升，歐洲也有望出現積極增長，需要立即採取行動。亞太地區也將效仿，分析師預測採用蛋白質芯片進行診斷將為該地區帶來利潤豐厚的機會。

本報告提供全球蛋白質晶片市場相關調查分析，提供市場動態，各地區預測，企業簡介等資訊。

目錄

第1章 摘要整理

  • 全球蛋白質晶片市場預測(2018年～2030年)
  • 全球蛋白質晶片市場成長機會(2018年～2030年)
  • 主要的產業趨勢

第2章 市場概要

  • 市場定義和市場區隔
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會矩陣
  • 波特的五力分析
  • 法規指南償付情勢
  • COVID-19影響的分析

第3章 價格分析(2021年)

  • 平均銷售價格:主要各地區

第4章 全球蛋白質晶片市場預測(2018年～2030年)

  • 全球蛋白質晶片市場預測:各技術(金額)(2018年～2030年)

第5章 全球蛋白質晶片市場預測(2018年～2030年)

  • 全球蛋白質晶片市場預測:各用途(金額)(2018年～2030年)
  • 全球蛋白質晶片市場預測:各終端用戶(金額)(2018年～2030年)
  • 全球蛋白質晶片市場預測:各地區(金額)(2018年～2030年)

第6章 北美的蛋白質晶片市場預測(2018年～2030年)

  • 北美的蛋白質晶片市場預測:各技術(金額)(2018年～2030年)
  • 北美的蛋白質晶片市場預測:各用途(金額)(2018年～2030年)
  • 北美的蛋白質晶片市場預測:各終端用戶(金額)(2018年～2030年)
  • 北美的蛋白質晶片市場預測:各國(金額)(2018年～2030年)

第7章 歐洲的蛋白質晶片市場預測(2018年～2030年)

  • 歐洲的蛋白質晶片市場預測:各技術(金額)(2018年～2030年)
  • 歐洲的蛋白質晶片市場預測:各用途(金額)(2018年～2030年)
  • 歐洲的蛋白質晶片市場預測:各終端用戶(金額)(2018年～2030年)
  • 歐洲的蛋白質晶片市場預測:各國(金額)(2018年～2030年)

第8章 亞太地區的蛋白質晶片市場預測(2018年～2030年)

  • 亞太地區的蛋白質晶片市場預測:各技術(金額)(2018年～2030年)
  • 亞太地區的蛋白質晶片市場預測:各用途(金額)(2018年～2030年)
  • 亞太地區的蛋白質晶片市場預測:各終端用戶(金額)(2018年～2030年)
  • 亞太地區的蛋白質晶片市場預測:各國(金額)(2018年～2030年)

第9章 其他地區的蛋白質晶片市場預測(2018年～2030年)

  • 其他地區的蛋白質晶片市場預測:各技術(金額)(2018年～2030年)
  • 其他地區的蛋白質晶片市場預測:各用途(金額)(2018年～2030年)
  • 其他地區的蛋白質晶片市場預測:各終端用戶(金額)(2018年～2030年)
  • 其他地區的蛋白質晶片市場預測:各國(金額)(2018年～2030年)

第10章 競爭情形

  • 企業的市場佔有率分析
  • 企業簡介
    • ArrayIt Corporation
    • PerkinElmer, Inc.
    • Thermo Fischer Scientific
    • Lumicyte
    • Bio-Rad Laboratories
    • Illumina, Inc.
    • Ciphergen Biosystems
    • Agilent Technologies
    • 其他

第11章 附錄

簡介目錄

The global protein chip market is experiencing rapid growth, driven by the increasing prevalence of chronic diseases and the demand for advanced treatment options. The evolution of the healthcare sector has been a major influencer for the market's growth, with a growing need for improved disease monitoring and clinical diagnostics. The protein microarray method, which allows for a wide range of analyses in a single experiment, has become a unique selling point, contributing to the market's expansion. Fairfield Market Research's preliminary findings indicate that the high prevalence of cancer worldwide is expected to underpin the growth of the protein chip market.

Protein Chip Market Benefitting from COVID-19 Outbreak and Cancer Prevalence

The outbreak of COVID-19 has highlighted the importance of diagnostics in containing the pandemic, leading to a surge in demand for functional analysis methods. This has made functional analysis a lucrative area of growth as researchers focus on identifying protein-virus interactions through various testing methods.

Cancer, on the other hand, remains a key cause of shortened life expectancy globally. According to the World Health Organization (WHO), there were over 19 million new cancer cases and approximately 10 million cancer-related deaths in 2020. The critical role of protein chips in efficient cancer diagnosis, allowing fast and easy diagnostics with parallel tracking of various protein interactions, targets, small molecules, substrates of protein kinases, and protein-phospholipid interactions, will drive market demand. The broad application scope of protein chips in molecular biology and biochemistry, along with the growing sector of personalized medicine, further enhances their significance in the healthcare industry.

Proteomics Emerges as the Leading Application for Protein Chips

As of 2019, proteomics stood as the leading application area for protein chips, and it is expected to maintain this position in the coming years. Its wide usage in biomedical research and drug discovery is anticipated to be a major revenue generator for the market. Proteomics is deployed in various techniques, including superficial fluid chromatography, chromatography, x-ray crystallography, protein fractionation, spectroscopy, surface plasmon resonance, and electrophoresis. Its ability to offer accurate analysis of in-vivo outcomes makes it an essential tool in the study of tumour resistance mechanisms, disease pathogenesis, and therapeutic developments.

North America and Europe to Lead the Global Protein Chip Market

North America is expected to maintain its dominance in the global protein chip market from 2021 to 2026. Well-established biotech companies in the region are projected to invest significantly in research and development of innovative technologies. Europe is also expected to show positive growth due to the rising incidence of cancer and COVID-19, prompting swift action. Analysts anticipate that Asia Pacific will closely follow this development, with protein chip adoption for diagnostics presenting lucrative opportunities in the region.

Key Players in the Global Protein Chip Market

The competitive landscape of the global protein chip market is shaped by leading players such as Sigma Aldrich Corporation, Affymetrix, Inc., Biacore, SEQUENOM, Inc., Illumina, Inc., Agilent Technologies, HTS Biosystems, EMD Millipore, Life Technologies Corporation, Lumicyte, and Ciphergen Biosystems.

Table of Contents

1. Executive Summary

  • 1.1. Global Protein Chip Market Outlook, 2018 - 2030 (US$ Million)
  • 1.2. Global Protein Chip Market Incremental Opportunity, 2018 - 2030 (US$ Million)
  • 1.3. Key Industry Trends

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
      • 2.2.1.1. Driver 1
      • 2.2.1.2. Driver 2
    • 2.2.2. Restraints
      • 2.2.2.1. Restraint 1
      • 2.2.2.2. Restraint 2
    • 2.2.3. Market Opportunities Matrix
  • 2.3. Porters Five Forces Analysis
  • 2.4. Regulatory Guidelines & Reimbursement Scenario
  • 2.5. Covid-19 Impact Analysis

3. Pricing Analysis, 2021

  • 3.1. Average Selling Price, by Key Regions

4. Global Protein Chip Market Outlook, 2018 - 2030

  • 4.1. Global Protein Chip Market Outlook, by Technology, Value (US$ Mn), 2018 - 2030
    • 4.1.1. Key Highlights
      • 4.1.1.1. Functional
      • 4.1.1.2. Analytical
      • 4.1.1.3. Reverse Phase
      • 4.1.1.4. Others
    • 4.1.2. BPS Analysis/Market Attractiveness Analysis

5. Global Protein Chip Market Outlook, 2018 - 2030

  • 5.1. Global Protein Chip Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
    • 5.1.1. Key Highlights
      • 5.1.1.1. Diagnostics
      • 5.1.1.2. Proteomics
      • 5.1.1.3. Drug Discovery
      • 5.1.1.4. Biomarker Research
      • 5.1.1.5. Others
    • 5.1.2. BPS Analysis/Market Attractiveness Analysis
  • 5.2. Global Protein Chip Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
    • 5.2.1. Key Highlights
      • 5.2.1.1. Pharmaceutical & Biotech Companies
      • 5.2.1.2. Hospitals & Clinics
      • 5.2.1.3. Diagnostic Laboratories
      • 5.2.1.4. Research Institutes
      • 5.2.1.5. Others
    • 5.2.2. BPS Analysis/Market Attractiveness Analysis
  • 5.3. Global Protein Chip Market Outlook, by Region, Value (US$ Mn), 2018 - 2030
    • 5.3.1. Key Highlights
      • 5.3.1.1. North America
      • 5.3.1.2. Europe
      • 5.3.1.3. Asia Pacific
      • 5.3.1.4. Rest of the World
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. North America Protein Chip Market Outlook, 2018 - 2030

  • 6.1. North America Protein Chip Market Outlook, by Technology, Value (US$ Mn), 2018 - 2030
    • 6.1.1. Key Highlights
      • 6.1.1.1. Functional
      • 6.1.1.2. Analytical
      • 6.1.1.3. Reverse Phase
      • 6.1.1.4. Others
    • 6.1.2. BPS Analysis/Market Attractiveness Analysis
  • 6.2. North America Protein Chip Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
    • 6.2.1. Key Highlights
      • 6.2.1.1. Diagnostics
      • 6.2.1.2. Proteomics
      • 6.2.1.3. Drug Discovery
      • 6.2.1.4. Biomarker Research
      • 6.2.1.5. Others
    • 6.2.2. BPS Analysis/Market Attractiveness Analysis
  • 6.3. North America Protein Chip Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
    • 6.3.1. Key Highlights
      • 6.3.1.1. Pharmaceutical & Biotech Companies
      • 6.3.1.2. Hospitals & Clinics
      • 6.3.1.3. Diagnostic Laboratories
      • 6.3.1.4. Research Institutes
      • 6.3.1.5. Others
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis
  • 6.4. North America Protein Chip Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
    • 6.4.1. Key Highlights
      • 6.4.1.1. U.S.
      • 6.4.1.2. Canada
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Europe Protein Chip Market Outlook, 2018 - 2030

  • 7.1. Europe Protein Chip Market Outlook, by Technology, Value (US$ Mn), 2018 - 2030
    • 7.1.1. Key Highlights
      • 7.1.1.1. Functional
      • 7.1.1.2. Analytical
      • 7.1.1.3. Reverse Phase
      • 7.1.1.4. Others
    • 7.1.2. BPS Analysis/Market Attractiveness Analysis
  • 7.2. Europe Protein Chip Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
    • 7.2.1. Key Highlights
      • 7.2.1.1. Diagnostics
      • 7.2.1.2. Proteomics
      • 7.2.1.3. Drug Discovery
      • 7.2.1.4. Biomarker Research
      • 7.2.1.5. Others
    • 7.2.2. BPS Analysis/Market Attractiveness Analysis
  • 7.3. Europe Protein Chip Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
    • 7.3.1. Key Highlights
      • 7.3.1.1. Pharmaceutical & Biotech Companies
      • 7.3.1.2. Hospitals & Clinics
      • 7.3.1.3. Diagnostic Laboratories
      • 7.3.1.4. Research Institutes
      • 7.3.1.5. Others
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis
  • 7.4. Europe Protein Chip Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
    • 7.4.1. Key Highlights
      • 7.4.1.1. Germany
      • 7.4.1.2. France
      • 7.4.1.3. U.K.
      • 7.4.1.4. Italy
      • 7.4.1.5. Spain
      • 7.4.1.6. Rest of Europe
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Asia Pacific Protein Chip Market Outlook, 2018 - 2030

  • 8.1. Asia Pacific Protein Chip Market Outlook, by Technology, Value (US$ Mn), 2018 - 2030
    • 8.1.1. Key Highlights
      • 8.1.1.1. Functional
      • 8.1.1.2. Analytical
      • 8.1.1.3. Reverse Phase
      • 8.1.1.4. Others
    • 8.1.2. BPS Analysis/Market Attractiveness Analysis
  • 8.2. Asia Pacific Protein Chip Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
    • 8.2.1. Key Highlights
      • 8.2.1.1. Diagnostics
      • 8.2.1.2. Proteomics
      • 8.2.1.3. Drug Discovery
      • 8.2.1.4. Biomarker Research
      • 8.2.1.5. Others
    • 8.2.2. BPS Analysis/Market Attractiveness Analysis
  • 8.3. Asia Pacific Protein Chip Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
    • 8.3.1. Key Highlights
      • 8.3.1.1. Pharmaceutical & Biotech Companies
      • 8.3.1.2. Hospitals & Clinics
      • 8.3.1.3. Diagnostic Laboratories
      • 8.3.1.4. Research Institutes
      • 8.3.1.5. Others
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis
  • 8.4. Asia Pacific Protein Chip Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
    • 8.4.1. Key Highlights
      • 8.4.1.1. China
      • 8.4.1.2. Japan
      • 8.4.1.3. India
      • 8.4.1.4. South Korea
      • 8.4.1.5. Australia & New Zealand
      • 8.4.1.6. Rest of Asia Pacific
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Rest of the World Protein Chip Market Outlook, 2018 - 2030

  • 9.1. Rest of the World Protein Chip Market Outlook, by Technology, Value (US$ Mn), 2018 - 2030
    • 9.1.1. Key Highlights
      • 9.1.1.1. Functional
      • 9.1.1.2. Analytical
      • 9.1.1.3. Reverse Phase
      • 9.1.1.4. Others
    • 9.1.2. BPS Analysis/Market Attractiveness Analysis
  • 9.2. Rest of the World Protein Chip Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
    • 9.2.1. Key Highlights
      • 9.2.1.1. Diagnostics
      • 9.2.1.2. Proteomics
      • 9.2.1.3. Drug Discovery
      • 9.2.1.4. Biomarker Research
      • 9.2.1.5. Others
    • 9.2.2. BPS Analysis/Market Attractiveness Analysis
  • 9.3. Rest of the World Protein Chip Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
    • 9.3.1. Key Highlights
      • 9.3.1.1. Pharmaceutical & Biotech Companies
      • 9.3.1.2. Hospitals & Clinics
      • 9.3.1.3. Diagnostic Laboratories
      • 9.3.1.4. Research Institutes
      • 9.3.1.5. Others
    • 9.3.2. BPS Analysis/Market Attractiveness Analysis
  • 9.4. Rest of the World Protein Chip Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
    • 9.4.1. Key Highlights
      • 9.4.1.1. Latin America
      • 9.4.1.2. Middle East & Africa
    • 9.4.2. BPS Analysis/Market Attractiveness Analysis

10. Competitive Landscape

  • 10.1. Company Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1. ArrayIt Corporation
      • 10.2.1.1. Company Overview
      • 10.2.1.2. Financial Overview
      • 10.2.1.3. Technology Portfolio
      • 10.2.1.4. Recent Developments
    • 10.2.2. PerkinElmer, Inc.
    • 10.2.3. Thermo Fischer Scientific
    • 10.2.4. Lumicyte
    • 10.2.5. Bio-Rad Laboratories
    • 10.2.6. Illumina, Inc.
    • 10.2.7. Ciphergen Biosystems
    • 10.2.8. Agilent Technologies
    • 10.2.9. Others

11. Appendix

  • 11.1. Research Methodology
  • 11.2. Report Assumptions
  • 11.3. Acronyms and Abbreviations